Agilent Technologies Inc. has announced the opening of the Dissolution Centre of Excellence (CoE) facility in Craven Arms, United Kingdom (UK). The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more.

Dissolution testing is an important tool for characterizing the performance of oral solid dosage forms.

This investment allows all Agilent dissolution activities to be consolidated under one roof, facilitating the cooperation of all business segments and driving the mission of innovation for the next generation of dissolution products and services.

The COVID-19 pandemic has highlighted the need for improving virtual connectivity, with many companies seeking new ways to strengthen contact with customers. This expanded site will serve as a hub for Agilent’s dissolution customers around the world, providing education, training, application development, and both on-site and virtual demonstrations. These enhanced capabilities demonstrate Agilent’s adaptation to this new model of doing business while providing a channel for customers to easily access expertise and support.